This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish (read more).

Clinical Services

Clinical Manufacturing

PCI offers a broad range of services to address the manufacturing needs of our clients at each stage of the product lifecycle. Central to PCI’s international service offering is our capability to manufacture a range of dosage forms in compliance with current GMP standards.

For over 30 years, we have been successfully developing pharmaceutical dosage forms. Our strength lies in the integrated nature of our services, combining formulation development and analytical services with clinical trial supplies for both potent and non-potent molecules. This comprehensive yet flexible package is delivered with close coordination of each stage of the development process by our experienced project management team.

Our facilities have been designed to allow flexibility in processing technology and are approved for the manufacture of investigational and commercial products. With a comprehensive range of qualified analytical equipment and extensive stability storage resources, we are able to develop and validate analytical methods to support development programs.

By combining formulation and analytical testing with GMP clinical trial manufacturing and packaging, we are able to offer a seamless service throughout your development journey.

Our dedicated team of specialists will be happy to discuss any of your Clinical Manufacturing needs. Contact us on +1 815-484-1528 (US) or +44 1495 713 633 (UK) or email sales@pciservices.com


PCI Pharma Services at CPhI Worldwide 2017

PCI Pharma Services will be at CPhI Worldwide (October 24-26, Frankfurt, Germany, Stand 4.F30), reinforcing our reputation for providing the... View Article

Free Educational Serialization and Anti-Counterfeiting Forum

PCI Pharma Services, in collaboration with Antares, Crest Solutions, 3C Integrity, Multi-Packaging Solutions (MPS) and media partner Manufacturing Chemist, will... View Article

x